<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Selection of CFTR modulator therapy for patients with cystic fibrosis who are &lt;2 years old</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Selection of CFTR modulator therapy for patients with cystic fibrosis who are &lt;2 years old</h1>
<div class="graphic"><div class="figure"><div class="ttl">Selection of CFTR modulator therapy for patients with cystic fibrosis who are &lt;2 years old</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">The above table shows mutations approved for IVA by the US Food and Drug Administration as of May 2023. Other options for CFTR modulator therapy will be available for most patients once they reach ≥2 years of age.</div><div class="graphic_footnotes"><p>CFTR: cystic fibrosis transmembrane conductance regulator; CF: cystic fibrosis; IVA: ivacaftor (KALYDECO); LUM-IVA: lumacaftor-ivacaftor (ORKAMBI); ELX-TEZ-IVA: elexacaftor-tezacaftor-ivacaftor (TRIKAFTA).</p>
<p>* For patients who are F508del homozygotes, we suggest LUM-IVA for ages 1 to 2 years, then advancing to ELX-TEZ-IVA at age 2 years. F508del homozygotes are also eligible for TEZ-IVA, but the drug is not approved for children less than 6 years old.</p>
¶ For patients who are not eligible for any available CFTR modulator, consider enrollment in a clinical trial, if available for the patient's genotype and age.</div><div class="graphic_reference">Data from:
<ol>
<li>ORKAMBI® (lumacaftor/ivacaftor) Tablets and Oral Granules. Vertex Pharmaceuticals Incorporated. Available at: <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206038s010lbl.pdf" target="_blank">https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211358s004lbl.pdf</a> (Accessed on September 9, 2022).</li>
<li>KALYDECO® (ivacaftor) Tablets and Oral Granules. Vertex Pharmaceuticals Incorporated. Available at: <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207925s016lbl.pdf" target="_blank">https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207925s016lbl.pdf</a> (Accessed on May 9, 2023).</li>
</ol></div><div id="graphicVersion">Graphic 130531 Version 7.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
